Mordechai Friedman, Director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), sold 5,000 shares at $2.57 ($13K) on 2015-12-14, disclosed to the SEC on 2015-12-16.
Open-market sale of $13k BCLI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.